PMC:7408073 / 112126-112338
Annnotations
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T229 | 59-62 | Body_part | denotes | RAS | http://purl.obolibrary.org/obo/UBERON_0018229 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3767 | 173-180 | Disease | denotes | failure | MESH:D006333 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T115 | 92-94 | http://purl.obolibrary.org/obo/CLO_0050475 | denotes | my |
T116 | 147-148 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T117 | 171-172 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T52971 | 59-62 | Chemical | denotes | RAS | http://purl.obolibrary.org/obo/CHEBI_63620 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T556 | 0-212 | Sentence | denotes | In this regard, I have tried to address all aspects of the RAS inhibition in detail because my main concern is that the use of these approaches in a wrong way may lead to a failure or even to deleterious effects. |